InNexus Biotechnology (InNexus Biotechnology) EPS (Basic) : $-0.04 (TTM As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology EPS (Basic)?

InNexus Biotechnology's basic earnings per share (Basic EPS) for the three months ended in Mar. 2011 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.04.

InNexus Biotechnology's EPS (Diluted) for the three months ended in Mar. 2011 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.04.

InNexus Biotechnology's EPS without NRI for the three months ended in Mar. 2011 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2011 was -0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

InNexus Biotechnology EPS (Basic) Historical Data

The historical data trend for InNexus Biotechnology's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology EPS (Basic) Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

EPS (Basic)

Get a 7-Day Free Trial

-0.11

-0.12

-0.11

-0.10

-0.07

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EPS (Basic)	Get a 7-Day Free Trial															-0.02	-0.02	-0.01	-0.01	-

InNexus Biotechnology EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

InNexus Biotechnology's Basic EPS for the fiscal year that ended in Jun. 2010 is calculated as

Basic EPS (A: Jun. 2010 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.447	-	0)	/	96.337
	=	-0.07

InNexus Biotechnology's Basic EPS for the quarter that ended in Mar. 2011 is calculated as

Basic EPS (Q: Mar. 2011 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.569	-	0)	/	163.448
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04

InNexus Biotechnology (GREY:IXSBF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

InNexus Biotechnology EPS (Basic) Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines